MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer
2017 · Cancer Research · 264 citations
https://doi.org/10.1158/0008-5472.can-17-1636
H
Hasan Rajabi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
238
Papers
4.3K
Citations
43
h-index
59
i10-index
Hasan Rajabi is an academic researcher. The author has contributed to research in topics: Glycosylation and Glycoproteins Research & RNA modifications and cancer & Lung Cancer Research Studies. The author has an h-index of 43, co-authored 203 publications.
Papers by this author
worksTargeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells
2013 · Oncogene · 107 citations
https://doi.org/10.1038/onc.2013.308
Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
2014 · Oncotarget · 64 citations
https://doi.org/10.18632/oncotarget.1848
Oncogenic MUC1-C Promotes Tamoxifen Resistance in Human Breast Cancer
2013 · Molecular Cancer Research · 50 citations
https://doi.org/10.1158/1541-7786.mcr-12-0668
MUC1-C activates EZH2 expression and function in human cancer cells
2017 · Scientific Reports · 49 citations
https://doi.org/10.1038/s41598-017-07850-0
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation
2015 · Journal of Neuroinflammation · 41 citations
https://doi.org/10.1186/s12974-015-0460-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat